Understand why HGH should not be treated as an over-the-counter weight-loss product.
Human growth hormone is a prescription medication. Marketing that treats it like an over-the-counter fat-loss supplement strips away the clinical context that matters.
Body composition, endocrine disorders and legitimate indications require individualized medical evaluation. A scale number alone is not a diagnosis or an indication for HGH treatment.
The site also tracks Saxenda (liraglutide), Ozempic and Wegovy (semaglutide), Mounjaro (tirzepatide) and Rybelsus (oral semaglutide). These are not HGH products, even when they appear in the same broader weight-management research journey.
Similar commercial intent does not mean similar pharmacology. Frequency of administration, approved indication, active ingredient and formulation differ. Current reference pricing is consolidated on the homepage so visitors can compare listings without confusing the drug categories.